Pharmacological management of renal fibrotic disease

Author： Gaedeke Jens Neumayer Hans-H Peters Harm

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.4, 2006-03, pp. : 377-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Management of Peyronie's Disease

By Trost Landon W. Gur Serap Hellstrom Wayne J.G

Drugs, Vol. 67, Iss. 4, 2007-01 ,pp. : 527-545

Adis International

Access to resources Recommend Favorite

Pharmacological Management of Alzheimer's Disease

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 33, Iss. 1, 2003-03 ,pp. : 24-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacological Management of Parkinson's Disease

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 3, 2004-09 ,pp. : 229-232

John Wiley & Sons Inc

Access to resources Recommend Favorite

Connective tissue growth factor: an attractive therapeutic target in fibrotic renal disease

By Brady Hugh R Crean John KG Godson C Lappin DWP

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. : 519-530

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological management of polycystic kidney disease

By Wüthrich Rudolf P Mei Changlin

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 8, 2014-06 ,pp. : 1085-1095

Informa Healthcare

Access to resources Recommend Favorite